QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe
Go back to QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe| QUINTILES TRANSNATIONAL HOLDINGS, Inc. (NYSE: Q) | Delayed: 122.31 -2.19 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.50 | 52 Week High | $81.45 | |||
| Open | $122.03 | 52 Week Low | $55.01 | |||
| Day High | $123.45 | P/E | 69.10 | |||
| Day Low | $120.05 | EPS | $1.77 | |||
| Volume | 1,490,612 | |||||
